Global Neurological Disorder Drugs Sales Market Report 2021

Global Neurological Disorder Drugs Sales Market Report 2021

Table of Contents
1 Neurological Disorder Drugs Market Overview
1.1 Neurological Disorder Drugs Product Scope
1.2 Neurological Disorder Drugs Segment by Type
1.2.1 Global Neurological Disorder Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Antipsychotic
1.2.3 Hypnotic & Sedative
1.2.4 Analgesics
1.2.5 Anticoagulants
1.2.6 Others
1.3 Neurological Disorder Drugs Segment by Application
1.3.1 Global Neurological Disorder Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Neurological Disorder Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Neurological Disorder Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Neurological Disorder Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Neurological Disorder Drugs Price Trends (2016-2027)
2 Neurological Disorder Drugs Estimates and Forecasts by Region
2.1 Global Neurological Disorder Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Neurological Disorder Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Neurological Disorder Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Neurological Disorder Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Neurological Disorder Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Neurological Disorder Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Neurological Disorder Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Neurological Disorder Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Neurological Disorder Drugs Estimates and Projections (2016-2027)
2.4.3 China Neurological Disorder Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Neurological Disorder Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Neurological Disorder Drugs Estimates and Projections (2016-2027)
2.4.6 India Neurological Disorder Drugs Estimates and Projections (2016-2027)
3 Global Neurological Disorder Drugs Competition Landscape by Players
3.1 Global Top Neurological Disorder Drugs Players by Sales (2016-2021)
3.2 Global Top Neurological Disorder Drugs Players by Revenue (2016-2021)
3.3 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2020)
3.4 Global Neurological Disorder Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Neurological Disorder Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Neurological Disorder Drugs Market Size by Type
4.1 Global Neurological Disorder Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Neurological Disorder Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Neurological Disorder Drugs Price by Type (2016-2021)
4.2 Global Neurological Disorder Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neurological Disorder Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Neurological Disorder Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Neurological Disorder Drugs Price Forecast by Type (2022-2027)
5 Global Neurological Disorder Drugs Market Size by Application
5.1 Global Neurological Disorder Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Neurological Disorder Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Neurological Disorder Drugs Price by Application (2016-2021)
5.2 Global Neurological Disorder Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neurological Disorder Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Neurological Disorder Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Neurological Disorder Drugs Price Forecast by Application (2022-2027)
6 North America Neurological Disorder Drugs Market Facts & Figures
6.1 North America Neurological Disorder Drugs Sales by Company
6.1.1 North America Neurological Disorder Drugs Sales by Company (2016-2021)
6.1.2 North America Neurological Disorder Drugs Revenue by Company (2016-2021)
6.2 North America Neurological Disorder Drugs Sales Breakdown by Type
6.2.1 North America Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Neurological Disorder Drugs Sales Breakdown by Application
6.3.1 North America Neurological Disorder Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Neurological Disorder Drugs Sales Breakdown by Application (2022-2027)
7 Europe Neurological Disorder Drugs Market Facts & Figures
7.1 Europe Neurological Disorder Drugs Sales by Company
7.1.1 Europe Neurological Disorder Drugs Sales by Company (2016-2021)
7.1.2 Europe Neurological Disorder Drugs Revenue by Company (2016-2021)
7.2 Europe Neurological Disorder Drugs Sales Breakdown by Type
7.2.1 Europe Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Neurological Disorder Drugs Sales Breakdown by Application
7.3.1 Europe 115 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 115 Sales Breakdown by Application (2022-2027)
8 China Neurological Disorder Drugs Market Facts & Figures
8.1 China Neurological Disorder Drugs Sales by Company
8.1.1 China Neurological Disorder Drugs Sales by Company (2016-2021)
8.1.2 China Neurological Disorder Drugs Revenue by Company (2016-2021)
8.2 China Neurological Disorder Drugs Sales Breakdown by Type
8.2.1 China Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
8.3 China Neurological Disorder Drugs Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)
9 Japan Neurological Disorder Drugs Market Facts & Figures
9.1 Japan Neurological Disorder Drugs Sales by Company
9.1.1 Japan Neurological Disorder Drugs Sales by Company (2016-2021)
9.1.2 Japan Neurological Disorder Drugs Revenue by Company (2016-2021)
9.2 Japan Neurological Disorder Drugs Sales Breakdown by Type
9.2.1 Japan Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Neurological Disorder Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Neurological Disorder Drugs Market Facts & Figures
10.1 Southeast Asia Neurological Disorder Drugs Sales by Company
10.1.1 Southeast Asia Neurological Disorder Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Neurological Disorder Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Neurological Disorder Drugs Market Facts & Figures
11.1 India Neurological Disorder Drugs Sales by Company
11.1.1 India Neurological Disorder Drugs Sales by Company (2016-2021)
11.1.2 India Neurological Disorder Drugs Revenue by Company (2016-2021)
11.2 India Neurological Disorder Drugs Sales Breakdown by Type
11.2.1 India Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
11.3 India Neurological Disorder Drugs Sales Breakdown by Application
11.3.1 India Neurological Disorder Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Neurological Disorder Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Neurological Disorder Drugs Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Neurological Disorder Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Business Overview
12.2.3 GlaxoSmithKline Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Neurological Disorder Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck & Co.
12.3.1 Merck & Co. Corporation Information
12.3.2 Merck & Co. Business Overview
12.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck & Co. Neurological Disorder Drugs Products Offered
12.3.5 Merck & Co. Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Business Overview
12.4.3 Bayer Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Neurological Disorder Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Business Overview
12.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Neurological Disorder Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer Ingelheim Neurological Disorder Drugs Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Corporation Information
12.7.2 Teva Pharmaceutical Business Overview
12.7.3 Teva Pharmaceutical Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Neurological Disorder Drugs Products Offered
12.7.5 Teva Pharmaceutical Recent Development
...
13 Neurological Disorder Drugs Manufacturing Cost Analysis
13.1 Neurological Disorder Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neurological Disorder Drugs
13.4 Neurological Disorder Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neurological Disorder Drugs Distributors List
14.3 Neurological Disorder Drugs Customers
15 Market Dynamics
15.1 Neurological Disorder Drugs Market Trends
15.2 Neurological Disorder Drugs Drivers
15.3 Neurological Disorder Drugs Market Challenges
15.4 Neurological Disorder Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Neurological Disorder Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Neurological Disorder Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Neurological Disorder Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Neurological Disorder Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Neurological Disorder Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Neurological Disorder Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Neurological Disorder Drugs Revenue Share by Region (2016-2021)
Table 8. Global Neurological Disorder Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Neurological Disorder Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Neurological Disorder Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Neurological Disorder Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Neurological Disorder Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Neurological Disorder Drugs Sales Share by Company (2016-2021)
Table 14. Global Neurological Disorder Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Neurological Disorder Drugs Revenue Share by Company (2016-2021)
Table 16. Global Neurological Disorder Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Drugs as of 2020)
Table 17. Global Neurological Disorder Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Neurological Disorder Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Neurological Disorder Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Neurological Disorder Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Neurological Disorder Drugs Sales Share by Type (2016-2021)
Table 23. Global Neurological Disorder Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Neurological Disorder Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Neurological Disorder Drugs Sales Share by Type (2022-2027)
Table 26. Global Neurological Disorder Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Neurological Disorder Drugs Revenue Share by Type (2022-2027)
Table 28. Global Neurological Disorder Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Neurological Disorder Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Neurological Disorder Drugs Sales Share by Application (2016-2021)
Table 31. Global Neurological Disorder Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Neurological Disorder Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Neurological Disorder Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Neurological Disorder Drugs Sales Share by Application (2022-2027)
Table 35. Global Neurological Disorder Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Neurological Disorder Drugs Revenue Share by Application (2022-2027)
Table 37. Global Neurological Disorder Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Neurological Disorder Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Neurological Disorder Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Neurological Disorder Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Neurological Disorder Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Neurological Disorder Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Neurological Disorder Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Neurological Disorder Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Neurological Disorder Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Neurological Disorder Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Neurological Disorder Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Neurological Disorder Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Neurological Disorder Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Neurological Disorder Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Neurological Disorder Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Neurological Disorder Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Neurological Disorder Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Neurological Disorder Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Neurological Disorder Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Neurological Disorder Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Neurological Disorder Drugs Sales Market Share by Application (2022-2027)
Table 62. China Neurological Disorder Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Neurological Disorder Drugs Sales Market Share by Company (2016-2021)
Table 64. China Neurological Disorder Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Neurological Disorder Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Neurological Disorder Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Table 68. China Neurological Disorder Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Neurological Disorder Drugs Sales Market Share by Type (2022-2027)
Table 70. China Neurological Disorder Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Table 72. China Neurological Disorder Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Neurological Disorder Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Neurological Disorder Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Neurological Disorder Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Neurological Disorder Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Neurological Disorder Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Neurological Disorder Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Neurological Disorder Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Neurological Disorder Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Neurological Disorder Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Neurological Disorder Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Neurological Disorder Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Neurological Disorder Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Neurological Disorder Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Neurological Disorder Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Neurological Disorder Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Neurological Disorder Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Neurological Disorder Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Neurological Disorder Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Neurological Disorder Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Neurological Disorder Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Neurological Disorder Drugs Sales Market Share by Application (2022-2027)
Table 98. India Neurological Disorder Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Neurological Disorder Drugs Sales Market Share by Company (2016-2021)
Table 100. India Neurological Disorder Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Neurological Disorder Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Neurological Disorder Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Table 104. India Neurological Disorder Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Neurological Disorder Drugs Sales Market Share by Type (2022-2027)
Table 106. India Neurological Disorder Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Table 108. India Neurological Disorder Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Neurological Disorder Drugs Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Novartis Neurological Disorder Drugs Product
Table 114. Novartis Recent Development
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Business Overview
Table 117. GlaxoSmithKline Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. GlaxoSmithKline Neurological Disorder Drugs Product
Table 119. GlaxoSmithKline Recent Development
Table 120. Merck & Co. Corporation Information
Table 121. Merck & Co. Description and Business Overview
Table 122. Merck & Co. Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck & Co. Neurological Disorder Drugs Product
Table 124. Merck & Co. Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Bayer Neurological Disorder Drugs Product
Table 129. Bayer Recent Development
Table 130. AstraZeneca Corporation Information
Table 131. AstraZeneca Description and Business Overview
Table 132. AstraZeneca Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. AstraZeneca Neurological Disorder Drugs Product
Table 134. AstraZeneca Recent Development
Table 135. Boehringer Ingelheim Corporation Information
Table 136. Boehringer Ingelheim Description and Business Overview
Table 137. Boehringer Ingelheim Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Boehringer Ingelheim Neurological Disorder Drugs Product
Table 139. Boehringer Ingelheim Recent Development
Table 140. Teva Pharmaceutical Corporation Information
Table 141. Teva Pharmaceutical Description and Business Overview
Table 142. Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Teva Pharmaceutical Neurological Disorder Drugs Product
Table 144. Teva Pharmaceutical Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Neurological Disorder Drugs Distributors List
Table 148. Neurological Disorder Drugs Customers List
Table 149. Neurological Disorder Drugs Market Trends
Table 150. Neurological Disorder Drugs Market Drivers
Table 151. Neurological Disorder Drugs Market Challenges
Table 152. Neurological Disorder Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Disorder Drugs Product Picture
Figure 2. Global Neurological Disorder Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Antipsychotic Product Picture
Figure 4. Hypnotic & Sedative Product Picture
Figure 5. Analgesics Product Picture
Figure 6. Anticoagulants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurological Disorder Drugs Sales Market Share by Application in 2021 & 2027
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Neurological Disorder Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Neurological Disorder Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Neurological Disorder Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Neurological Disorder Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Neurological Disorder Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Neurological Disorder Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Neurological Disorder Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Neurological Disorder Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Neurological Disorder Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Neurological Disorder Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Neurological Disorder Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Neurological Disorder Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Neurological Disorder Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Neurological Disorder Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Neurological Disorder Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Neurological Disorder Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Neurological Disorder Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Neurological Disorder Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Neurological Disorder Drugs Players Market Share by Revenue in Neurological Disorder Drugs: 2016 & 2020
Figure 30. Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Neurological Disorder Drugs Revenue Share by Type (2016-2021)
Figure 32. Global Neurological Disorder Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Neurological Disorder Drugs Revenue Share by Application (2016-2021)
Figure 34. Global Neurological Disorder Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 36. North America Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 37. Europe Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 38. Europe Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 39. China Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 40. China Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 41. Japan Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 42. Japan Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 43. Southeast Asia Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 44. Southeast Asia Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 45. India Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 46. India Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Neurological Disorder Drugs
Figure 49. Manufacturing Process Analysis of Neurological Disorder Drugs
Figure 50. Neurological Disorder Drugs Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Loratadine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Loratadine market size was valued at US$ 138.8 million in 2023. With growing demand in downstream market, the Loratadine is forecast to a readjusted size of US$ 175.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Loratadine market. Loratadine are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Allergy Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Allergy Rhinitis Drugs market: According to our latest research, the global Allergy Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergy Rhinitis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overrea......

Global Loratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Loratadine market: According to our latest research, the global Loratadine market looks promising in the next 5 years. As of 2022, the global Loratadine market was estimated at USD 145.21 million, and it's anticipated to reach USD 210.61 million in 2028, with a CAGR of 6.39% during the forecast years. Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching,......

Global Desloratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Desloratadine market: According to our latest research, the global Desloratadine market looks promising in the next 5 years. As of 2022, the global Desloratadine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Desloratadine market, with a sys......

Global Clarityne Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Clarityne market: According to our latest research, the global Clarityne market looks promising in the next 5 years. As of 2022, the global Clarityne market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clarityne market, with a systematical descri......

Global Allergic Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Allergic Rhinitis Drugs market: According to our latest research, the global Allergic Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergic Rhinitis Drugs market was estimated at USD 3956.8 million, and it's anticipated to reach USD 5997.75 million in 2028, with a CAGR of 7.18% during the forecast years. Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous sub......

Global Desloratadine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 107

Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis. The global Desloratadine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Desloratadine is estimated to increase from $ million......

Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 96

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson's Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing ris......

Global Allergic Rhinitis Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 125

In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system. The global Allergic Rhinitis Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs